Speaker:                     Sarah Anand, MD

         Hematology/Oncology Fellow

         Dept of Medicine

          Duke Health

Topic:                          “Looking back at UCB transplant, looking forward to

             chronic GVHD prevention”

Date:                           Tuesday, November 15, 2016

NEW Time:                 8:00 a.m. – 9:00 a.m.

Location:                     9015 North Pavilion

Summary of Faculty Disclosure/Planning Committee
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CE activity: Sarah Anand, MD.

The following speakers and/or planning committee members have indicated they have relationship(s) with industry to disclose: Dr. Mitchell Horwitz has indicated that he is on the Advisory Board Member for Genzyme and is the Principal Investigator for both Otsuka and Pfizer.

Joint Accreditation Statement

In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
 

Education Credits

Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.